| PACKAGING TYPE: | 10x10 ( 10 Strips In 1 Box) |
| COMPOSITION: | Tofacitinib Extended Release 22mg Tablet |
| FORMULATION: | Tablets |
| Description: | ARTOFA-ER 22 Tablet contains Tofacitinib Extended Release 22 mg, a Janus kinase (JAK) inhibitor used in the treatment of autoimmune and inflammatory conditions such as Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis. Tofacitinib works by blocking the activity of Janus kinase enzymes involved in the inflammatory process. By reducing inflammatory signaling, ARTOFA-ER 22 Tablet helps relieve joint pain, swelling, stiffness, and improves physical function in patients with chronic autoimmune diseases. The extended-release formulation allows once-daily dosing for improved treatment adherence. |
| Side Effects: | Some individuals may experience mild side effects such as: Headache Nausea Upper respiratory tract infections Diarrhea Increased cholesterol levels Seek medical attention if severe symptoms such as infections, chest pain, or allergic reactions occur. |
| How to Use: | Take ARTOFA-ER 22 Tablet exactly as prescribed by a healthcare professional. Swallow the tablet whole with water; do not crush or chew. It may be taken with or without food. Take the medication at the same time each day for best results. |
| Precaution: | Use only under strict medical supervision. Inform your doctor if you have liver disease, kidney disease, or weakened immune system. Patients should be screened for tuberculosis before starting therapy. Avoid live vaccines during treatment. Pregnant or breastfeeding women should consult a healthcare professional before use. Regular monitoring of blood counts and liver function may be required. Store in a cool and dry place away from direct sunlight. Keep out of reach of children. |
| Product Benefits: | Helps reduce joint pain, swelling, and stiffness. Effective in managing rheumatoid arthritis and psoriatic arthritis. Helps control inflammation in ulcerative colitis. Supports long-term management of autoimmune diseases. Extended-release formulation |
| Expiry Date: | 2027-04-04 |
Frequently Asked Questions
ARTOFA-ER 22 Tablet is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Tofacitinib blocks Janus kinase enzymes that trigger inflammation, helping reduce symptoms of autoimmune diseases.
The extended-release form allows once-daily dosing, which improves convenience and treatment adherence.










